NCAM1 and neoplasm: Besides these factors, Linn et al. [47] describe the lack in CD62L and CD27 expression of the CD3+CD56+ subset, which is critical for lymphoid homing properties and anti-tumor immunity, as another imaginable reason for the reduced long-term efficacy of CIK cells [47].